| Application no. and date | 22156880.1 (espacenet) (Federated) (European Patent Register), 20180727 | | Patent/reg. no. and date | DK/EP 4019039, 20231011 | | Publication date | 20220629 | | Priority no. and date | FR 1757172, 20170727, FR 1757184, 20170728, FR 1855250, 20180614 | | EP pub. no. and date |
EP 4019039 20220629 | | Effective date | | | Applicant/owner | Adocia, 115, Avenue Lacassagne
69003 Lyon, FR | | Applicant ref. no. | V469341DKEP | | Inventor | CHAN, You-Ping,
69360 TERNAY, FR | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/198 (2006.01) , A61K 38/26 (2006.01) , A61K 38/28 (2006.01) , A61K 45/06 (2006.01) , A61K 47/02 (2006.01) , A61K 9/08 (2006.01) , C07K 14/62 (2006.01) , A61P 3/10 (2006.01) , A61P 5/48 (2006.01) | | Title | Sammensætninger i form af en injicerbar vandig opløsning, som omfatter mindst et humant insulin A21G og en glucagonundertrykker med prandial virkning | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
